JMUST Mandatory Disclosures

Chief Editor

Raymond L. Rosales, MD, PhD 

  1. Research Internal Funding: UST-RCHS- Parkinsonism Research Projects  
  2. Research External Funding: Michael J. Fox Parkinson Disease Foundation (USA)-GP2 Projects
  3. Research External Funding: CCXDP-Massachusetts General Hospital/Sunshine Foundation (USA)-XDP Advisory Project
  4. Research External Funding: University of Lübeck (Germany)-XDP Gene Project
  5. Research External Funding: Palacky University (Czeck Rep)-Visiting Professor and Neurodegeneration Research Projects
  6. Journal International Editorial Board Membership:
    a. Associate Editor: Nature Parkinsons Disease, Frontiers of Neurology (Behavioral Neuroscience)
    b. Board Member: Journal of Movement Disorders, Clinical-Parkinsonism and Related Disorders
  7. Advisory Board and CME Formulation Grants: Ipsen International, Otsuka Philippines, Viatris Philippines, Sun Pharma Philippines

Associate Editor

Leilani M. Asis, MD

No Conflict of Interest


Assistant Editor

Warren R Bacorro, MD

No Conflict of Interest


Board of Advisors

Ma. Lourdes Domingo-Maglinao, MD

Nothing to disclose


Rev. Fr. Angel Aparicio, OP

Nothing to disclose


Rev. Fr. Julius Paul Factora, OP, J.C.D.

Nothing to disclose


Charito Malong-Consolacion, RN, MD

Nothing to disclose


International Editorial Board Members

Edgar V. Lerma, MD

Ownership Interest: Fresenius Joint Venture

Consultancy and Honararia: Akebia, Astra Zeneca, Bayer, Boehringer Ingelheim, Glaxo Smith Kline, Otsuka, Travere, Vifor

Research Funding: Nothing to disclose

Patents/Royalties: UpToDate, McGraw-Hill Publishing, Elsevier Publishing, Wolters Kluwer Publishing, Springer


Hubert H. Fernandez, MD

Research Funding: 

  1. Chair Parkinson Study Group, USA
  2. Editor-in-Chief, Parkinsonism and Related Disorders
  3. Multiple clinical drug trials on Parkinson Disease


Cecilia M. Lansang, MD, MPH

Research Funding:

  1. Multiple clinical drug trials on Diabetes Mellitus


May Christine V. Malicdan, MD, PhD

Translational Laboratory Director, National Institutes of Health, Bethesda, Maryland


  1. Patent Application No. US 20120264928 A1, Satoru Noguchi, May Christine Malicdan, Ichizo Nishino (Inventors). Therapeutic pharmaceutical agent for diseases associated with decrease in function of gene protein, food composition, and food additive. 23 M. Malicdan, MD, PhD – 08192022
  2. Gne-/-hGNED176VTg as a mouse model for DMRV/HIBM (Japanese patent-2010). Satoru Noguchi, Nishino Kazumi, May Christine Malicdan (Inventors) • NIH provisional patent No. 62/120,742 (filed Feb 2015) “Sialylation-Increasing Therapies for Diseases Associated with Oxidative Stress”
  3. Patent Application No. 15/061829, filed on March 4, 2016, entitled “CANNABINOID RECEPTOR MEDIATING COMPOUNDS


Jose Leonardo V. Mejino, Jr., MD

Consultancy: Dorlands’ Illustrated Medical Dictionary, Anatomy Next, Exonicus Inc.


Maria-Kassandra Endaya Coronel, MD

Nothing to disclose


Criselle Angeline C. Peñamante, MD, MA

Nothing to disclose


Editorial Board Members

Encarnita Ampil, MD

  1. External funding from the Department of Science and Technology (DOST) -  PCHRD on the DAShS project, mental health among university students
  2. External funding from NYU Langone Health, Observational Study of COVID-19 related neurological disorders and Chronic Neuropsychiatric sequelae


David T. Bolong, MD

No Conflict of Interest


Aileen Cynthia F. De Lara, MD

No Conflict of Interest


Nilo C. Delos Santos, MD

No Conflict of Interest


Maria Honolina S. Gomez, MD

  1. Research Internal Funding: UST-RCHS-  mySugar mobile app study
  2. Research External Funding: Roche Philippines (as an Investigator -Initiated Study)


Ramon M. Gonzalez, MD

No Conflict of Interest


Norberto V. Martinez, MD

No Conflict of Interest


Erick S. Mendoza, MD

No Conflict of Interest


Patrick Gerard L. Moral, MD

No Conflict of Interest


Marcellus Francis L. Ramirez, MD

  1. Advisory Board - Boehringer Ingelheim, Philippines for Dabigatran, Empagliflozin, Telmisartan
  2. Key opinion leader - Menarini Philippines for Ranolazine
  3. Speaker’s honorarium - Boehringer Ingelheim, Menarini, Pfizer, LRI Therapharma, Bayer, Zydus, Otsuka, Servier
  4. CME Travel Grant - Medtronic
  5. Editor-in-Chief Philippine Journal of Cardiology


Leah Socorro N. Rivera, MD

No Conflict of Interest


Wilfredo R. Santos, MD

No Conflict of Interest


Consuelo B. Gonzalez-Suarez, MD, PhD

  1. Research Internal Funding: UST-RCHS- Patellofemoral Pain Syndrome project
  2. Research External Funding: Department of Science and Technology-Research Center: Sports Medicine/Rehabilitation


Julie T. Li-Yu, MD

No Conflict of Interest